Table 1.
Participant characteristics of the CHS All Stars (2005–2006)
| With thyroid testing (n = 1049) |
No thyroid testing (n = 628) | ||
|---|---|---|---|
| No thyroid medication use (n = 843) | Thyroid medication use (n = 206) | ||
| Age (yr) | 85.3 (3.7) | 85.3 (3.3) | 86.2 (4.1) |
| Female sex | 513 (60.9) | 159 (77.2) | 444 (70.7) |
| Nonwhite race | 154 (18.3) | 22 (10.7) | 113 (18.0) |
| BMI (kg/m2) | 26.6 (4.5) | 27.3 (5.1) | 27.0 (4.5)a |
| TSH (mU/liter) | 2.99 (5.07) | 3.45 (4.47) | |
| FT4 (ng/dl) | 1.22 (0.01) | 1.41 (0.02) | |
| Total T3 (ng/dl) | 103.9 (19.5) | 90.9 (19.5) | |
| TPOAb (U/liter) | 27.8 (67.8) | 66.5 (133.8) | |
All values given as mean (sd) or n (%). Thyroid medication use defined as thyroid hormone replacement or antithyroid medication. To convert FT4 to nanomoles per liter, multiply by 12.87. To convert total T3 to nanomoles per liter, multiply by 0.0154. BMI, Body mass index.
a
Available only on n = 74 of those without thyroid testing.